Cargando…

Risk Factors Associated With Outpatient Parenteral Antibiotic Therapy Program Failure Among Intravenous Drug Users

Sixty-one percent of intravenous drug users (IVDUs) who received outpatient parenteral antibiotic therapy (OPAT) failed treatment. Hospital readmission and adverse drug reactions occurred in 25%. By multivariate analysis, time since last IVDU was associated with failure (P = .04). Intravenous drug u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buehrle, Deanna J., Shields, Ryan K., Shah, Neel, Shoff, Christopher, Sheridan, Kathleen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493937/ https://www.ncbi.nlm.nih.gov/pubmed/28680904 http://dx.doi.org/10.1093/ofid/ofx102

Ejemplares similares

Impact of the Coronavirus Disease 2019 Pandemic on Outpatient Antibiotic Prescriptions in the United States
por: Buehrle, Deanna J, et al.
Publicado: (2020)

Comparing Injecting Drug Users with Others Receiving Outpatient Parenteral Antibiotic Therapy
por: Dobson, Pauline M, et al.
Publicado: (2017)

1301 Outpatient Parenteral Antimicrobial Therapy (OPAT) in Intravenous Drug Users (IVDUs): Epidemiology and Outcomes
por: Papalekas, Eleni, et al.
Publicado: (2014)

763. 30 Day Readmission Outcomes in Patients Over 80 Years of Age Enrolled in an Outpatient Parenteral Antibiotic Therapy (OPAT) Program
por: Sheridan, Kathleen R, et al.
Publicado: (2019)

Vancomycin or Daptomycin for Outpatient Parenteral Antibiotic Therapy: Does It Make a Difference in Patient Satisfaction?
por: Wu, Katherine H, et al.
Publicado: (2021)

Once-daily tigecycline for outpatient parenteral antibiotic therapy: a single-centre observational study
por: Hughes, Stephen, et al.
Publicado: (2019)

Trends in Outpatient Antibiotic Prescriptions in the United States During the COVID-19 Pandemic in 2020
por: Buehrle, Deanna J., et al.
Publicado: (2021)

Educational Resource Review: Intravenous to oral switch: within outpatient parenteral antibiotic therapy (IVOST)
Publicado: (2021)

1942. Expansion of Outpatient Parenteral Therapy Program with Addition of Advanced Practice Providers Can Lead to Reduced Readmission Rates
por: Wingfield, Joshua, et al.
Publicado: (2018)

Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis
por: Duncan, Christopher J. A., et al.
Publicado: (2013)

Home-Based Outpatient Parenteral Antibiotic Therapy at an Urban Safety Net Hospital: Comparing Outcomes in Persons With and Without Noninjection Drug Use
por: Appa, Ayesha, et al.
Publicado: (2020)

Perspectives on the Use of Outpatient Parenteral Antibiotic Therapy for People who Inject Drugs: Results From an Online Survey of Infectious Diseases Clinicians
por: Solomon, Daniel A, et al.
Publicado: (2023)

Health-Related Quality of Life in Outpatient Parenteral Antimicrobial Therapy
por: Keller, Sara C, et al.
Publicado: (2018)

Outpatient Parenteral Antibiotic Therapy (OPAT) Serial Readmissions and High Utilizers: Drilling Down on Readmission Following Discharge on Intravenous Antibiotics
por: Andrews, Mary-Margaret, et al.
Publicado: (2017)

First-Dose Antimicrobial Infusion Reactions in Patients Enrolled in Outpatient Parenteral Antimicrobial Therapy Services
por: Kovacik, Carrie N, et al.
Publicado: (2023)

Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy—Boston, Massachusetts, 2016–2021
por: Gupta, Akash, et al.
Publicado: (2023)

Value and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy Program
por: Petrak, Russell M., et al.
Publicado: (2016)

Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis
por: Tu, Jacky, et al.
Publicado: (2023)

Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy
por: Johnson, Tanner M., et al.
Publicado: (2023)

The Seroprevalence of COVID-19 in Intravenous Drug Users in Comparison to Non-drug Users
por: Mohammadi, Zahra, et al.
Publicado: (2021)

591. A Model for assessing staffing needs for an Outpatient Parenteral Antibiotic Therapy (OPAT) program
por: Munsiff, Sonal, et al.
Publicado: (2020)

A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs
por: Gelman, Stephanie S, et al.
Publicado: (2021)

1027. Outpatient Parenteral Antimicrobial Therapy (OPAT) in Injection Drug Users (IDUs): Is It Safe?
por: Rizvi, Hira, et al.
Publicado: (2018)

Managing an outpatient parenteral antibiotic therapy team: challenges and solutions
por: Halilovic, Jenana, et al.
Publicado: (2014)

First Pediatric Outpatient Parenteral Antibiotic Therapy Clinic in Indonesia
por: Hendarto, Aryono, et al.
Publicado: (2020)

Engaging Patients and Caregivers in a Transdisciplinary Effort to Improve Outpatient Parenteral Antimicrobial Therapy
por: Keller, Sara C, et al.
Publicado: (2020)

Reflections on implementation of a failure-point–focused outpatient parenteral antimicrobial therapy management program
por: Hemenway, Alice N., et al.
Publicado: (2022)

1940. Outcomes Among Patients Enrolled in an Outpatient Parenteral Antibiotic Therapy Program at an Academic Medical Center
por: Theodore, Deborah, et al.
Publicado: (2018)

A broader view on outpatient parenteral antibiotic therapy (OPAT) stewardship
por: Hess, Danielle, et al.
Publicado: (2022)

Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implications
por: Connors, William J., et al.
Publicado: (2017)

217. Broad Spectrum Antibiotic use in Outpatient Parenteral Antibiotic Therapy (OPAT): Opportunities for Antibiotic Stewardship
por: Brenon, Jessa R, et al.
Publicado: (2020)

Home self-administration of intravenous antibiotics as part of an outpatient parenteral antibiotic therapy service: a qualitative study of the perspectives of patients who do not self-administer
por: Tonna, Antonella, et al.
Publicado: (2019)

A clinical and in vitro assessment of outpatient parenteral benzylpenicillin and ceftriaxone combination therapy for enterococcal endovascular infections
por: Ingram, Paul R, et al.
Publicado: (2021)

Rate of broad-spectrum antibiotic overuse in patients receiving outpatient parenteral antibiotic therapy (OPAT)
por: Brenon, Jessa R., et al.
Publicado: (2021)

Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy
por: Underwood, Jonathan, et al.
Publicado: (2019)

Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry
por: Martone, W J, et al.
Publicado: (2008)

Adverse Events and Healthcare Utilization Associated With Outpatient Parenteral Antimicrobial Therapy Among Older Versus Younger Adults
por: Brzozowski, Kaylen, et al.
Publicado: (2020)

Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy
por: Marks, Michael, et al.
Publicado: (2020)

Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy
por: Jamieson, Conor, et al.
Publicado: (2021)

Multifocal neuropathy and Horner’s syndrome due to disseminated pyomyositis in an intravenous drug user
por: de Souza , Aaron, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_otib1c0voamg81dv61b2a5ro9t